Abstract
The chapter discusses about the critical role of CYP2E1 in ethanol mediated liver injury and its association with NASH. Ethanol metabolism by CYP2E1 generates hydroxyethyl radicals which promote ethanol hepatotoxicity. Greater induction of CYP2E1 and hence greater liver injury occurs with co-administration of ethanol and drugs. Induction of CYP2E1 leads to prominent epigenetic effects and CYP2E1 polymorphism may be associated with alcoholic liver disease. These are some aspects of CYP2E1, amongst many others which account for its importance in the context of drug metabolism and disease development and have been reviewed in the chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albano E (2002) Free radical mechanisms in immune reactions associated with alcoholics liver disease. Free Radic Biol Med 32(2):110–114
Albano E, Parola M, Comoglio A, Dianzani MV (1993) Evidence for the covalent binding of hydroxyethyl radicals to rat liver microsomal proteins. Alcohol Alcohol 28(4):453–459
Albano E, Clot P, Morimoto M, Tamasi A, Ingelman-Sundberg M, French SW (1996) Role of cytochrome P450 2E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 23(1):155–163
Albano E, French SW, Ingelman-Sundberg M (1998) Cytochrome P450 2E1, Hydroxyethyl free radicals and immune reactions associated with alcoholic liver injury. Alcohol Clin Exp Res 22:740–742
Albano E, French SW, Ingelman-Sundberg M (1999) Hydroxyethyl radicals in ethanol hepatotoxicity. Front Biosci 4:D533–D540
Amet Y, Lucas D, Zhang-Gouillon ZQ, French SW (1998) P450-dependent metabolism of lauric acids in alcoholic liver disease: comparison between rat liver and kidney microsomes. Alcohol Clin Exp Res 22(2):455–462
Amet Y, Plee-Gautier E, Berthou F, Adas F, French SW (2000) Adaption to chronic ethanol administration emphasized by fatty acid hydroxylations in rat liver and kidney microsomes. Eur J Nutr 39(6):270–276
Amidi F, French BA, Chung D, Halsted C, Medici V, French SW (2007) M30 and 4 HNE adducts are sequestered in different aggresomes in the same hepatocytes. Exp Mol Pathol 83(3):296–300
Banerjee A, Kocarek TA, Novak RF (2000) Identification an ubiquination-target/substrate-interaction domain of cytochrome P-450 (CYP2E1). Drug Metab Dispos 28(2):118–124
Bardag-Gorce F, Yuan QX, Li J, French BA, Fang C, Ingelman-Sundberg M, French SW (2000) The effect of ethanol-induced cytochrome P450 2E1 on the inhibition of proteasome activity by alcohol. Biochem Biophys Res Commun 279(1):23–29
Bardag-Gorce F, French BA, Lue YH, Nguyen V, Wan YJ, French SW (2001) Mallory body formation in proteasome-depleted hepatocytes: an immunohistochemical study. Exp Mol Pathol 70(1):7–18
Bardag-Gorce F, van Leeuwen F, Nguyen V, French B, Li J, Riley N, McPhaul L, Lue Y, French SW (2002a) The role of ubiquitin-proteasome pathway in the formation of Mallory bodies. Exp Mol Pathol 73(2):75–83
Bardag-Gorce F, French BA, Li J, Riley NE, Yuan QX, Valinluk V, Fu P, Ingelman-Sundberg M, Yoon G, French SW (2002b) The importance of cycling of blood alcohol levels in the pathogenesis of experimental alcoholic liver disease in rats fed ethanol intragastrically. Gastroenterology 123(1):325–335
Bardag-Gorce F, Wilson TL, Nan L, Morgan TR, Morgan K, French SW (2005) The CYP2E1 inhibition enhances Mallory body formation. Exp Mol Pathol 78(3):207–211
Bardag-Gorce F, French BA, Nan L, Song H, Nguyen SK, Yong H, Dedes J, French SW (2006a) CYP2E1 induced by ethanol causes oxidative stress and proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp Mol Pathol 81(3):191–201
Bardag-Gorce F, French BA, Dedes J, Li J, French SW (2006b) Gene expression patterns of the liver in response to alcohol: in vivo and in vitro models compared. Exp Mol Pathol 80(3):241–251
Butura A, Nilsson K, Morgan K, Morgan TR, French SW, Johansson I, Schuppe-Koistinen I, Ingelman-Sundberg M (2008) The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J Hepatol 50(3):572–583
Caetano R, Clark CL (1998) Trends in alcohol consumption patterns among whites, blacks and Hispanics: 1984 and 1985. J Stud Alcohol 59(6):659–668
Caro AA, Cederbaum AI (2001) Synergistic toxicity of iron and arachidonic acid in HepG2 cells over expressing CYP2E1. Mol Pharmacol 60(4):742–752
Caro AA, Cederbaum AI (2004) Oxidative stress, toxicology and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44:27–42
Clot P, Tabone M, Arico S, Albano E (1994) Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut 35(11):1637–1643
Clot P, Bellomo G, Talone M, Arico S, Albano E (1995) Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis. Gastroenterology 108(1):201–207
Clot P, Albano E, Elliasson E, Tabone M, Arico S, Isreael Y, Monocada C, Ingelman-Sundberg M (1996) Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigenic determinant for autoantibody formation among alcoholics. Gastroenterology 111(1):206–216
Clot P, Parola M, Belomo G, Dianzani U, Carini U, Tabone M, Arivo S, Ingelman-Sundberg M, Albano E (1997) Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology 113(1):265–276
DeLemos-Chiarandini C, Frey AB, Sabatini DD, Kreibich G (1987) Determination of the membrane topology of the phenobarbital-inducible rat liver cytochrome P450 isozyme PB-4 using site specific antibodies. J Cell Biol 104(2):209–219
Deng Q-G, She H, Cheng JH, French SW, Koop DR, Xiong S, Tsukamoto H (2005) Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42(4):905–914
Dey A, Cederbaum AI (2007) Induction of cytochrome promotes liver injury in ob/ob mice. Hepatology 45(6):1355–1365
Donohue TM Jr, Zetterman RK, Zhang-Gouillon ZQ, French SW (1998) Peptidase activities of the multicatalytic proteasome in rat liver after voluntary and intragastric ethanol administration. Hepatology 28(2):486–491
Dupont I, Lucas D, Clot P, Monez C, Albano E (1998) Cytochrome P-450 2E1 inducibility and hydroxyethyl radical formation among alcoholics. J Hepatol 28(4):564–571
Esfandiari F, Villanueva JA, Wong WH, French SW, Halsted CH (2005) Chronic ethanol feeding and folate deficiency activate endoplasmic reticulum stress pathways in micropigs. Am J Physiol Gastrointest Liver Physiol 289(1):G54–G63
Fataccioli V, Andraud E, Gentil M, French SW, Rouach H (1999) Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress. Hepatology 29(1):14–20
French SW (1989) Biochemical basis for alcohol-induced liver injury. Clin Biochem 22(1):41–49
French SW (2001) Gene expression of the liver at the peaks and troughs of the blood alcohol cycle in rats fed ethanol continuously intragastrically: a most ingenious paradox. In: Crews FT (ed) Summary report of a symposium: genes and gene delivery for diseases of alcoholism. Alcohol Clin Exp Res 25(12):1778–1800, IIA2
French SW, Ihrig TJ, Morin RJ (1970) Lipid composition of liver mitochondria and microsomes and erythrocyte ghosts after chronic ethanol feeding. Q J Stud Alcohol 31(4):801–807
French SW, Wong K, Albano E, Hagbjörk A-L, Ingelman-Sundberg M (1993) Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation and serum protein adduct formation in relation to liver pathology pathogenesis. Exp Mol Pathol 58(1):61–75
French SW, Morimoto M, Reitz R, Koop D, Klopfenstein B, Estes K, Clot P, Ingelman-Sundberg M, Albano E (1997) Lipid peroxidation, CYP2E1, and fatty acid metabolism in alcoholic liver disease. J Nutr 127(5 Suppl):9075–9115
French SW, Mayer F, Bardag-Gorce F, Ingelman-Sundberg M, Rouach H, Neve E, Higashitsuji H (2001) The ubiquitin-proteasome 26s pathway in liver cell protein turnovers: effect of ethanol and drugs. Alcohol Clin Exp Res 25((5 Suppl ISBRA)):225s–229s
Gebhardt AC, Lucas D, Menez JF, Seitz HK (1997) Chlormethiazole inhibition of cytochrome P450-2E1 as assessed by chlorzoxasone hydroxylation in humans. Hepatology 26(4):957–996
Goasduff T, Cederbaum A (2000) CYP2E1 degradation by in vivo reconstitution systems: role of the molecular chaperone hsp90. Arch Biochem Biophys 379(2):321–330
Gonzalez-Quintela A, Garcia J, Campos J, Perez LF, Alende MR, Otero F, Abdulkader I, Tomé S (2006) Serum cytokeratins in alcoholic liver diseases: contrasting levels of cytokeratin 18 and cytokeratin-19. Alcohol 38(1):45–49
Gouillon ZQ, Miyamoto K, Donohue TM, Wan Y-Y, French BA, Nagao Y, Fu P, Reitz RC, Hagbjork A-L, Yap C, Ingelman-Sundberg M, French SW (1999) Role of CYP2E1 in the pathogenesis of alcoholic liver disease: modifications by cAMP and ubiquitin-proteasome pathway. Front Biosci 4:16–25
Gouillon Z, Lucas D, Li J, Hagbjork AL, French BA, Fu P, Fang C, Ingelman-Sundberg M, Donohue TM Jr, French SW (2000) Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 224(4):302–308
Hayashi SI, Watanabe J, Kawajiri IS (1991) Genetic polymorphism in the 5′-flanking region change transcriptional regulation of the human cytochrome. P450 11E1 gene. J Biochem 110(4):559–565
French SW Cyclic change in gene expression when rats are fed alcoholic at a constant rate in Nanji AA, Su GL, Laposata M, French SW (2002) Pathogenesis of alcoholic liver disease – recent advances. Alcohol Clin Exp Res 26(5):731–736
Kanayama R, Takase S, Matsuda Y, Takada A (1984) Effect of dietary fat upon ethanol metabolism in rats. Biochem Pharmacol 33(20):3282–3287
Kathirvel E, Morgan K, French SW, Morgan TR (2009) Over expression of liver-specific cytochrome P4502E1 impairs hepatic insulin signalling in transgenic mouse model of non-alcoholic fatty liver disease. Eur J Gastroenterol Hepatol 21(9):973–983
Kathirvel E, Chen P, Morgan K, French SW, Morgan TR (2010) Oxidative stress and regulation of anti-oxidant enzymes in cytochromes P4502E1 transgenic mouse model of non-alcoholic fatty liver. J Gastroenterol Hepatol 25(6):1136–1143
Konishi T, Calvillo M, Leng A-S, Feng J, Lee T, Lee H, Smith JL, Sial SH, Berman N, French S, Eysselein V, Lin KM, Wan YJ (2003) The ADH3*2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican-American men. Exp Mol Pathol 74(2):183–189
Korsmeyer KK, Davoll S, Figueiredo-Peirera ME, Correia MA (1999) Proteolytic degradation of heme modified hepatic cytochrome P450: a role for phosphorylation, ubiquitination and the 26s proteasome. Arch Biochem Biophys 365(1):31–44
Lee SST, Buters JTM, Pineau T, Fernandez-Salguero S (1996) Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 271(20):12063–12067
Li J, French B, Wu Y, Vankatesh R, Montgomery R, Bardag-Gorce F, Kitto J, French SW (2004) Liver hypoxia and lack of recovery after reperfusion at high blood alcohol levels in the intragastric feeding model of alcohol liver disease. Exp Mol Pathol 77(3):184–192
Lieber CS (1999) Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968–1998). A review. Alcohol Clin Exp Res 23(6):993–1007
Lytton SD, Helander A, Zhang-Gouillon ZQ, Stokkeland K, Bordone R, Arico S, Albano E, French SW, Ingelman-Sundberg M (1999) Autoantibodies against cytochrome P450s 2E1 and 3A in alcoholics. Mol Pharmacol 55(2):223–233
Moncada C, Torres V, Varghese E, Albano E, Israel Y (1994) Ethanol derived immunoreactive species formed by free radical mechanisms. Mol Pharmacol 46(4):786–791
Morgan K, French SW, Morgan TR (2002) Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36(1):122–134
Morimoto M, Hagbjork A-L, Nanji AA, Fu P, Ingelman-Sundberg M, Lindros KO, Albano E, French SW (1993) Role of Cytochrome P450 2E1 in alcoholic liver disease pathogenesis. Alcohol 10(6):459–464
Morimoto M, Reitz RC, Morin RJ, Nguyen K, Ingelman-Sundberg M, French SW (1995a) Fatty acid composition of hepatic lipids in rats fed ethanol and high fat diet intragastrically. Effect of CYP2E1 inhibitors. J Nutr 125(12):2953–2964
Morimoto M, Hagbjork A-L, Wan Y-J Y, Fu P, Clot P, Albano E, Ingelman-Sundberg M, French SW (1995b) Modulation of experimental alcoholic liver disease by cytochrome P450 2E1 inhibitors. Hepatology 21(6):1610–1617
Nordman R, Ribiere C, Rouach H (1992) Implications of free radical mechanism in ethanol induced cellular injury. Free Radic Biol Med 12(3):219–240
Nordmann R (1994) Alcohol and antioxidant systems. Alcohol 29(5):513–522
Robert BJ (1997) Evidence of proteasome-mediated cytochrome P450 degradation. J Biol Chem 272(15):9771–9778
Robert BJ, Song BJ, Soh Y, Park SS, Shoaf SE (1995) Ethanol induces CYP2E1 by protein stabilization. J Biol Chem 270(50):29632–29635
Rouach H, Fataccioli V, Gentil M, French SW, Morimoto M, Nordmann R (1997) Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology 25(2):351–355
Sakaguchi M, Mihara K, Sato RA (1987) A short amino-terminal segment of microsomal cytochrome P450 functions both as an insertion signal and as a stop-transfer sequence. EMBO J 6(8):2425–2431
Schattenberg JM, Wang Y, Singh R, Rigoli RM, Czaja MJ (2005) Hepatocyte CYP2E1 over expression and steatohepatitis lead to compared insulin signaling. J Biol Chem 280(11):9887–9894
Song B, Veech RL, Park SS, Gelboin HV, Gonzales FJ (1989) Induction of rat hepatic N-nitrosodimethylmamine demethylase by acetone is due to protein stabilization. J Biol Chem 264(6):3568–3572
Takahashi H, Johansson I, French SW, Ingelman-Sundberg M (1992) Effects of dietary fat composition on activities of the microsomal ethanol oxidizing system and ethanol-induceable cytochrome P450 in liver of rats chronically fed ethanol. Pharmacol Toxicol 70((5 Pt. 1)):347–351
Tsukamoto H, Towner SJ, Ciofalo LM, French SW (1986) Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 6(5):814–822
Tsutsumi M, Wang JS, Takase S, Takada A (1994) Hepatic messenger RNA contents of cytochrome P4502E1 in patients with different P4502E1 genotypes. Alcohol 29(1):29–32
Vidali M, Occhino G, Ivaldi A, Serino R, Moia S, Alchera E, Carini R, Rigamonti C, Sartori M, Albano E (2002) Detection of auto-antibodies against cytochrome P450-2E1 (CYP2E1) in chronic hepatitis C. J Hepatol 46(4):605–612
Wang HF, Figuerado-Pereria ME, Correla AM (1999) Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes. Arch Biochem Biophys 365(1):45–53
Weltman MD, Farrell G, Liddle C (1996) Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatitis steatosis with inflammation. Gastroenterology 111(6):1645–1653
Weltman MD, Farrell G, Hall P, Ingelman-Sundberg M, Liddle C (1999) Hepatic cytochrome P450 2E1 is increased in patients with non-alcoholic steatohepatitis. Hepatology 27(1):128–213
Wu D, Cederbaum AI (1996) Ethanol cytotoxicity to a transfected HepG2 cell line expressing human cytochrome P450OE1. J Biol Chem 271(39):23914–23919
Yang MX, Cederbaum AI (1996) Role of the proteasome complex in degradation of human CYP2E1 in transfected HepG2 cells. Biochem Biophys Res Commun 236:711–716
Zhang-Gouillon ZQ, Yuan QX, Hu B, Marceau N, French BA, Gaal K, Nagao Y, Wan YJY, French SW (1998) Alcohol induces Mallory body formation in drug primed mice. Hepatology 27(1):116–122
Acknowledgement
The author thanks Adriana Flores for typing the manuscript and Barbara French for editing it.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
French, S.W. (2013). The Importance of CYP2E1 in the Pathogenesis of Alcoholic Liver Disease and Drug Toxicity and the Role of the Proteasome. In: Dey, A. (eds) Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism. Subcellular Biochemistry, vol 67. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5881-0_4
Download citation
DOI: https://doi.org/10.1007/978-94-007-5881-0_4
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5880-3
Online ISBN: 978-94-007-5881-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)